Log In
BCIQ
Print this Print this
 

CG100

  Manage Alerts
Collapse Summary General Information
Company Therabron Therapeutics Inc.
DescriptionRecombinant human club cell 10kD protein (rhCC10)
Molecular Target Secretoglobin family 1A member 1 (SCGB1A1) (CC10)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationBronchopulmonary dysplasia (BPD)
Indication DetailsPrevent bronchopulmonary dysplasia (BPD)
Regulatory Designation U.S. - Orphan Drug (Prevent bronchopulmonary dysplasia (BPD));
EU - Orphan Drug (Prevent bronchopulmonary dysplasia (BPD))
PartnerEMS S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today